BLAIR WILLIAM & CO/IL - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$14,000
-6.7%
440
-25.4%
0.00%
Q1 2021$15,000
+25.0%
590
+24.2%
0.00%
Q4 2020$12,000
+33.3%
475
+11.8%
0.00%
Q3 2020$9,000
+28.6%
425
+46.6%
0.00%
Q2 2020$7,000
-22.2%
290
-44.8%
0.00%
Q1 2020$9,000
-77.5%
525
-68.7%
0.00%
Q4 2019$40,000
-91.0%
1,675
-85.0%
0.00%
-100.0%
Q4 2017$445,000
+58.9%
11,171
+59.4%
0.00%
+50.0%
Q3 2017$280,0007,0100.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders